BARRY CAYSON: Open Payments
NPI 1447655352 · WINTER HAVEN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$555 in 29 payments from 12 companies in 2025. Trend: 2023 $200 · 2024 $946 · 2025 $555
Food & beverage: $555
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $150 |
| Amgen Inc. | 5 | $91 |
| Novo Nordisk Inc | 3 | $58 |
| PFIZER INC. | 3 | $57 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $38 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $35 |
| TOLMAR, INC. | 1 | $24 |
| ABBVIE INC. | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Esperion Therapeutics, Inc. | 1 | $23 |
Products named: FARXIGA, AIRSUPRA, NURTEC ODT, JARDIANCE, Ozempic, REPATHA, OTEZLA, Kerendia.
Industry payments across FL — which companies pay providers there.
